TFS
ONC

Thoroughbred Financial Services’s BeOne Medicines Ltd ONC Stock Holding History

Thoroughbred Financial Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
773
– – 0.01% 593
2026
Q1 		$229K Hold
773
– – 0.01% 540
2025
Q4 		$234K Sell
773
-13
-2% -$4.25K 0.01% 524
2025
Q3 		$267K Buy
+786
New +$239K 0.02% 495

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Thoroughbred Financial Services's ONC Position: Q2 2026 in Review

Thoroughbred Financial Services held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 773 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #593.

Thoroughbred Financial Services first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $267K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Thoroughbred Financial Services held 773 shares of BeOne Medicines Ltd worth $220K as of Q2 2026.
  • Thoroughbred Financial Services left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.01% of Thoroughbred Financial Services's portfolio in Q2 2026, its #593 holding.
  • Thoroughbred Financial Services first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • Thoroughbred Financial Services's BeOne Medicines Ltd position peaked at $267K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.